DM Clinical Research
Private Company
Funding information not available
Overview
DM Clinical Research operates a network of clinical trial sites, functioning as both a site management organization (SMO) and a service provider to sponsors and CROs. Headquartered in Houston with a reported 700+ employees, the company has built an 18+ year track record conducting trials across multiple therapeutic areas. Its business model leverages direct patient recruitment, including an ambassador program, and provides full-service clinical research execution, with a notable involvement in COVID-19 vaccine trials as part of the #HoustonFightsCOVID initiative. The company appears to be a private, revenue-generating services firm in the clinical research sector.
Technology Platform
Integrated network of clinical trial investigator sites and operational processes for trial management, including a patient referral 'Ambassador Program'. Capabilities likely include standard clinical trial infrastructure (EDC, CTMS) and recruitment tools.
Opportunities
Risk Factors
Competitive Landscape
DM Clinical competes in the fragmented clinical trial site services market against large global CROs with site networks, other regional Site Management Organizations (SMOs), and independent research sites. Differentiation is based on recruitment speed, patient diversity, site performance, and therapeutic expertise.